1. Introduction

A confidentiality breach in joint research occurs when a party involved in collaborative research improperly discloses, uses, transfers, or exploits confidential information belonging to another participant without proper authorization.

Joint research commonly takes place between universities, biotechnology companies, pharmaceutical manufacturers, hospitals, government laboratories, startups, and independent researchers. These collaborations often involve the exchange of unpublished research results, genetic data, biological samples, trade secrets, experimental methods, source code, patentable inventions, and commercially sensitive information.

The legal challenge is to balance three competing interests:

Protection of confidential information: Preventing unauthorized disclosure or commercial exploitation.

Freedom of scientific research: Allowing researchers to publish, verify, and build upon scientific findings.

Public interest: Ensuring that confidentiality does not improperly conceal research misconduct, safety risks, or legally reportable information.

The legal consequences depend on the collaboration agreement, the nature of the information, the circumstances of disclosure, and the jurisdiction in which the dispute arises.

2. Meaning and essential elements

A confidentiality breach in joint research may occur when one collaborator shares another party's unpublished findings with a competitor, uses jointly developed technology outside the agreed project, publishes results before obtaining a required review, or transfers research data to an unauthorized third party.

A claimant will generally need to establish the following elements, depending on the applicable cause of action:

Confidential character: The information was not generally available to the public and possessed the necessary confidential quality.

Obligation of confidence: The defendant was subject to an express or implied duty of confidentiality.

Unauthorized disclosure or use: The information was disclosed, misused, or exploited beyond the permitted purpose.

Knowledge or circumstances creating responsibility: The recipient knew, or should reasonably have understood, that the information was confidential.

Loss or threatened harm: The breach caused, or threatens to cause, commercial loss, reputational damage, loss of patent rights, or another legally recognized injury.

Not every element is required in identical form for every legal claim. For example, some remedies may be available to prevent an imminent breach before financial damage has occurred.

3. Common forms of confidentiality breaches

A breach may be committed intentionally, negligently, or through inadequate security controls, depending on the applicable legal framework.

4. Legal framework governing confidentiality in joint research

A. Contractual confidentiality

The principal safeguard is usually a written research collaboration agreement, often supported by a non-disclosure agreement (NDA).

Such agreements should define:

What constitutes confidential information.

The permitted purposes for using research data and materials.

Who owns pre-existing intellectual property and newly developed inventions.

When research results may be published.

Whether information may be disclosed to sponsors, regulators, or subcontractors.

How information must be returned, deleted, or retained after termination.

The remedies available following unauthorized disclosure.

In India, the Indian Contract Act, 1872, is central to contractual claims. Section 37 addresses the obligation to perform contractual promises, while Section 73 provides for compensation for loss or damage caused by breach of contract, subject to its requirements and limitations.

A confidentiality clause cannot automatically prevent every future use of knowledge. Its enforceability depends on its wording, the applicable law, public policy, and the nature of the restriction.

B. Equitable duty of confidence

A duty of confidence may arise even without a formal NDA. If a researcher receives information in circumstances that make its confidential nature apparent, the law may restrict unauthorized disclosure or exploitation.

This is particularly important in joint research, where parties exchange sensitive information before signing a final agreement.

The leading English authority is Coco v A.N. Clark (Engineers) Ltd [1969] RPC 41. It establishes the familiar three-part framework: confidential information, circumstances imposing an obligation of confidence, and unauthorized use to the detriment of the person communicating it.

Bailii+1

C. Trade-secret protection

Research information may qualify as a trade secret where it has commercial value because it is secret and is protected through reasonable confidentiality measures.

Examples include:

Unpublished experimental protocols.

Proprietary manufacturing processes.

Research algorithms and technical designs.

Non-public datasets and research findings.

Formulations, assays, and commercially valuable know-how.

India does not have a single comprehensive trade-secret statute equivalent to some foreign trade-secret laws. Protection instead relies substantially on contracts, principles of breach of confidence, and applicable intellectual-property and other laws.

Chambers and Partners+1

D. Data protection and research ethics

Joint research involving identifiable human participants, genetic information, medical records, or sensitive personal datasets raises additional legal questions.

Depending on the facts, relevant requirements may arise under:

The Digital Personal Data Protection Act, 2023, and applicable implementing provisions.

The Information Technology Act, 2000, and applicable rules.

Institutional research ethics requirements.

Applicable clinical-trial, biomedical research, and human-participant protections.

The confidentiality of research data is distinct from ownership of that data. A university or company may control a database without having unlimited authority to disclose identifiable participant information. Likewise, consent to participate in research does not necessarily authorize every subsequent commercial use or transfer.

5. Important case laws

The following decisions provide significant principles for analysing confidentiality disputes in joint research. Some concern commercial or technical information rather than scientific collaboration specifically, but their legal reasoning can be applied where the relevant facts are comparable.

Case 1: Coco v A.N. Clark (Engineers) Ltd [1969] RPC 41

Court: High Court of Justice, England and Wales.

Facts and issue: The dispute concerned technical information communicated in connection with a proposed commercial arrangement. The claimant sought to prevent unauthorized use of information supplied for a limited purpose.

Legal principle: The court identified three requirements for a breach-of-confidence claim:

The information must have the necessary quality of confidence.

It must have been communicated in circumstances importing an obligation of confidence.

There must have been unauthorized use to the detriment of the person communicating it.

Application to joint research: If a biotechnology company supplies a university with an unpublished production method for a defined research project, the university cannot assume that the method may be used in an unrelated commercial project. The result will depend on the agreement, the circumstances of disclosure, and the evidence of misuse.

Significance: This is a foundational authority for analysing whether a research collaborator owes a duty of confidence.

Bailii+1

Case 2: Saltman Engineering Co Ltd v Campbell Engineering Co Ltd (1948) 65 RPC 203

Court: Court of Appeal, England and Wales.

Facts: The dispute involved engineering drawings and technical information supplied in circumstances indicating that the information was confidential and intended for a limited purpose.

Legal principle: Information may attract protection where it is communicated in confidence and is used without authorization. The fact that a formal contract does not fully define the parties' relationship does not necessarily eliminate the obligation of confidence.

Application to joint research: Engineering drawings, laboratory designs, technical specifications, or experimental protocols shared for a collaborative project may remain protected against unauthorized exploitation.

Significance: The decision is an important foundation for the equitable protection of confidential technical information and is discussed in Coco.

Bailii+1

Case 3: Attorney General v Guardian Newspapers Ltd (No 2) [1990] 1 AC 109

Court: House of Lords, United Kingdom.

Facts: Commonly known as the Spycatcher litigation, the case concerned the publication of information connected with a former security service officer's memoirs and official confidences.

Legal principle: The House of Lords examined the circumstances in which an obligation of confidence arises and the competing considerations relevant to restraining publication. The law of confidence is not confined to conventional contractual relationships.

Application to joint research: A research collaborator's duty may survive the end of a project, particularly where information remains confidential. However, the availability of an injunction can depend on whether the information is already public, the defendant's knowledge, and competing legal or public-interest considerations.

Significance: The case helps explain the scope and limits of confidentiality obligations beyond a simple NDA.

Bailii+1

Case 4: John Richard Brady v. Chemical Process Equipments Pvt. Ltd., AIR 1987 Delhi 372

Court: Delhi High Court, India.

Facts: The plaintiffs had shared technical drawings, specifications, and know-how relating to a fodder-production unit with a manufacturer under conditions of strict confidentiality. They alleged that the manufacturer subsequently used the disclosed information to produce a competing machine.

Legal principle: The Court recognized a prima facie basis for protecting confidential technical information and know-how through equitable relief. It considered the alleged misuse of information entrusted for a limited commercial purpose.

Application to joint research: Suppose a university and a biotech startup jointly develop a laboratory instrument. The startup shares proprietary engineering drawings with a manufacturing partner solely for component production. If the manufacturer uses those drawings to develop its own competing instrument, the decision provides a useful Indian authority for seeking protection against misuse.

Significance: This is a particularly relevant Indian precedent because it involved a commercial collaboration, technical know-how, confidential drawings, and alleged unauthorized exploitation.

Indian Kanoon+1

Case 5: Fairfest Media Ltd v. ITE Group Plc, decided 8 January 2015

Court: Calcutta High Court, India.

Facts: The dispute arose from a mutual non-disclosure agreement entered into in anticipation of a joint venture. The claimant alleged that information supplied during the negotiations had been used to further the respondents' business interests.

Legal principle: The Court discussed protection of confidential commercial information under contractual and equitable principles. It also emphasized the importance of identifying the information claimed to be confidential and demonstrating how it was misused.

The Court's analysis illustrates that signing an NDA alone does not automatically establish entitlement to every requested injunction. The claimant must provide adequate evidence and satisfy the applicable requirements for relief.

Application to joint research: A pharmaceutical company that shares unpublished drug-development strategies with a potential university partner should preserve evidence of exactly what was disclosed, when it was disclosed, the restrictions imposed, and how the recipient allegedly used it.

Significance: This is one of the more directly relevant Indian authorities for disputes arising from information shared during proposed collaborations and joint ventures.

Indian Kanoon+1

Case 6: Force India Formula One Team Ltd v. 1 Malaysia Racing Team Sdn Bhd [2012] EWHC 616 (Ch)

Court: High Court of Justice, England and Wales.

Facts and issue: The litigation concerned allegations involving confidential technical and commercial information in the highly competitive Formula One racing industry.

Legal principle: The Court reaffirmed the established principles governing breach of confidence, including the need for information to possess a confidential character and the possibility of a duty arising where the recipient knew or ought reasonably to have known that the information was confidential.

The decision also discusses the distinction between protectable trade secrets and an individual's general skill, knowledge, and experience.

Application to joint research: A scientist leaving a collaborative project may ordinarily use their professional expertise and general scientific knowledge. That does not automatically entitle them to take confidential experimental datasets, proprietary algorithms, or secret manufacturing processes belonging to the former collaborator.

Significance: The case helps courts and parties distinguish legitimate scientific competition from the misuse of protected research information.

Bailii+1

Case 7: Kerry Ingredients (UK) Ltd v. Bakkavor Group Ltd [2016] EWHC 2448 (Ch)

Court: High Court of Justice, England and Wales.

Legal principle: The judgment discusses the Coco framework and the importance of the confidential character of the information and the circumstances in which it was received. Information already in the public domain generally cannot be protected merely by labelling it confidential.

Application to joint research: A collaborator cannot ordinarily claim exclusive confidentiality over a published scientific technique simply because the technique was also discussed in a private research meeting. However, a genuinely secret combination of methods, unpublished implementation details, or a confidential dataset may still merit protection.

Significance: The decision is useful for assessing the boundaries of confidential research information, particularly where public scientific knowledge is combined with proprietary know-how.

Bailii+1

6. Application of Indian law to joint research disputes

For a dispute arising in India, the following legal provisions and principles may be relevant.

Section 72A of the Information Technology Act addresses certain disclosures of personal information obtained under a lawful contract, where the specified conditions concerning wrongful loss or gain and unauthorized disclosure are met. It is not a general criminal prohibition covering every disclosure of commercial research secrets.

IndiaCode+1

The applicability of the Digital Personal Data Protection Act, 2023, and its implementing provisions should be checked against the relevant processing activity, commencement notifications, and rules in force at the time of the alleged breach.

7. Remedies available for a confidentiality breach

A. Injunction

A court may restrain a collaborator from disclosing, publishing, transferring, or commercially exploiting confidential research information where the applicable legal requirements are met.

For example, if a researcher threatens to transfer an unpublished proprietary dataset to a competing company, the information owner may seek urgent interim relief.

An injunction is not automatic merely because an NDA exists. The court considers the evidence, the nature of the threatened injury, the balance of convenience where relevant, and the governing legal standards.

B. Damages and compensation

Where a contractual breach is established, the injured party may claim compensation under Section 73 of the Indian Contract Act, 1872, subject to proof of causation, remoteness, and other applicable requirements.

Potential losses may include:

Lost commercial opportunities.

Reasonable costs incurred in responding to the breach.

Proven loss of licensing revenue.

Losses associated with unauthorized commercial exploitation.

Other foreseeable and legally recoverable losses.

C. Return or destruction of confidential materials

Depending on the agreement and the available legal remedies, a court may order the return or destruction of improperly retained documents, research files, copies, or other confidential materials.

The order must account for any applicable legal obligations to preserve records or retain research data.

D. Account of profits

Where legally available, the claimant may seek an account of profits attributable to the wrongful use of confidential information. This remedy is not automatically available in every contractual confidentiality dispute.

E. Copyright or patent-related remedies

If the same conduct also infringes copyright or patent rights, additional remedies may be available under the relevant intellectual-property legislation. A confidentiality breach and an intellectual-property infringement are separate legal questions, even when they arise from the same facts.

8. Defences and limitations

A defendant accused of breaching confidentiality may rely on several arguments, depending on the circumstances.

Public-domain information: The information was already publicly available or had lawfully become public.

Independent development: The defendant developed the technology independently without using the claimant's confidential information.

Prior knowledge: The defendant possessed the information lawfully before receiving it from the claimant.

Authorized disclosure: The disclosure was permitted by the agreement, informed consent, or another applicable legal authorization.

Insufficient identification: The claimant has not clearly identified the specific information alleged to have been misused.

Expiry or limited scope: The relevant contractual obligation does not cover the particular information, use, or period in dispute.

Legal or public-interest disclosure: Disclosure was required or protected by applicable law, such as certain regulatory reporting or protected whistleblowing.

Scientific publication deserves particular attention. A collaboration agreement may impose a reasonable review period to identify confidential information or allow patent filings before publication. However, such a clause must be interpreted according to its wording and applicable law; it does not necessarily confer an unlimited veto over scientific publication.

9. Practical safeguards for joint research agreements

A well-drafted research collaboration agreement should address confidentiality before information is exchanged.

1. Define confidential information precisely

Specify protected datasets, technical documents, unpublished findings, biological materials, source code, and trade secrets.

2. Allocate ownership and access rights

Distinguish background intellectual property, jointly developed inventions, research results, and third-party materials.

3. Establish publication procedures

Set review periods for confidentiality and patent considerations, without unnecessarily obstructing legitimate scientific publication.

4. Implement technical safeguards

Use role-based access, encryption, audit logs, controlled data rooms, and documented authorization for transfers.

5. Plan for termination

Address the return or deletion of confidential materials, continuing secrecy obligations, record-retention duties, and post-project access.

10. Critical legal analysis

The central problem in joint research is that collaboration requires disclosure, while disclosure creates opportunities for misuse.

An overly broad confidentiality agreement may obstruct scientific progress, researcher mobility, and publication. Conversely, an agreement that fails to identify confidential information or regulate third-party access may leave valuable research vulnerable to exploitation.

The most effective legal approach combines:

Clearly defined contractual obligations.

Appropriate technical and organizational security.

Transparent intellectual-property ownership rules.

Evidence-based enforcement.

Proportionate protection of scientific publication and public-interest disclosures.

The cases discussed above show that courts generally examine the actual information, the circumstances in which it was disclosed, the restrictions governing its use, and the evidence of unauthorized exploitation. Merely asserting that a collaborator acted unfairly is not a substitute for identifying the confidential material and establishing the legal basis for relief.

11. Conclusion

Confidentiality breaches in joint research can give rise to contractual liability, equitable claims for breach of confidence, trade-secret disputes, data-protection issues, and intellectual-property proceedings. The precise remedies depend on the jurisdiction and the facts.

In India, John Richard Brady v. Chemical Process Equipments Pvt. Ltd. and Fairfest Media Ltd v. ITE Group Plc are particularly useful authorities for understanding protection of technical know-how and confidential information shared in commercial collaborations. The English decisions in Coco, Saltman Engineering, and Force India provide further guidance on the nature of confidential information and the obligations arising from its receipt.

The key legal principle is that information entrusted for a defined research purpose must not automatically be treated as freely available for unrelated use or disclosure.

For a more focused legal analysis, the next useful step would be to examine this topic specifically under Indian law, with statutory provisions, additional Indian judgments, and a case-law-based examination framework.